| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 72,647665 | 18/05/2026 | 1,03% | -0,11% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 71,130000 | 18/05/2026 | 0,78% | -0,71% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 70,550000 | 18/05/2026 | -0,48% | 2,44% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 145,530000 | 18/05/2026 | 8,71% | 37,33% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 145,475618 | 18/05/2026 | 8,94% | 37,80% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 104,960000 | 18/05/2026 | 8,70% | 25,19% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 103,750000 | 18/05/2026 | 5,71% | 15,91% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 165,470000 | 18/05/2026 | 9,02% | 40,46% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 134,020000 | 18/05/2026 | 8,44% | 34,68% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | MIXTO AGRESIVO GLOBAL | 134,083104 | 18/05/2026 | 8,68% | 35,15% | **** |
